By Marisa Wong
Morgantown, W.Va., Nov. 14 – Barclays Bank plc priced $1 million of 0% Strategic Accelerated Redemption Securities due Nov. 13, 2020 linked to the Nasdaq Biotechnology index, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be called at par of $10 plus an annualized call premium of 12.11% if the index closes at or above its initial level on any of four annual review dates.
The payout at maturity will be par unless the index falls, in which case investors will be exposed to any losses.
BofA Merrill Lynch is the agent.
| Issuer: | Barclays Bank plc
|
| Issue: | Strategic Accelerated Redemption Securities
|
| Underlying index: | Nasdaq Biotechnology index
|
| Amount: | $1 million
|
| Maturity: | Nov. 13, 2020
|
| Coupon: | 0%
|
| Price: | Par of $10
|
| Payout at maturity: | Par unless the index falls, in which case investors will be exposed to any losses
|
| Call: | At par plus an annualized call premium of 12.11% if the index closes at or above its initial level on any of four annual review dates
|
| Initial level: | 2,984.10
|
| Pricing date: | Nov. 9
|
| Settlement date: | Nov. 16
|
| Agent: | BofA Merrill Lynch
|
| Fees: | 2%
|
| Cusip: | 06745R727
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
